KKPCF Kaken Pharmaceutical Co., Ltd. Forecast, Technical & Fundamental Analysis

KKPCF saw its Stochastic Oscillator recovers from the overbought zone

The Stochastic Oscillator for KKPCF moved out of overbought territory on January 14, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 9 similar instances where the indicator exited the overbought zone. In of the 9 cases the stock moved lower. This puts the odds of a downward move at .

Technical Analysis (Indicators)

Bearish Trend Analysis

The Aroon Indicator for KKPCF entered a downward trend on January 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 23, 2025. You may want to consider a long position or call options on KKPCF as a result. In of 8 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

KKPCF moved above its 50-day moving average on January 08, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for KKPCF crossed bullishly above the 50-day moving average on January 08, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 6 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.061) is normal, around the industry mean (29.698). P/E Ratio (288.455) is within average values for comparable stocks, (76.061). KKPCF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.042). Dividend Yield (0.043) settles around the average of (0.030) among similar stocks. P/S Ratio (1.928) is also within normal values, averaging (72.584).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. KKPCF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KKPCF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.